Erasca, Inc. · NASDAQ:ERAS
Paradigm Biocapital Advisors LP's stake in Erasca, Inc. fell to 3.30% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Paradigm Biocapital Advisors LP's stake in Erasca, Inc. fell to 3.30%, 10,392,702 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 3.30%
- Shares
- 10,392,702
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 3.30% | 10,392,702 |
| Paradigm BioCapital Advisors GP LLC | 3.30% | 10,392,702 |
| Senai Asefaw, M.D. | 3.30% | 10,392,702 |
| Paradigm BioCapital International Fund Ltd. | 2.90% | 9,157,687 |
Source
Related
- Erasca, Inc.
- Paradigm Biocapital Advisors LP
- Erasca, Inc. shareholders
- Schedule 13G · Paradigm Biocapital Advisors LP · Jan 14, 2026
- Schedule 13G/A · Jonathan E. Lim · Aug 14, 2026
- Schedule 13G · Rtw Investments, LP · May 15, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 15, 2026
- Schedule 13G/A · Montanova Capital, LLC · May 12, 2026